OCGN Ocugen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: OCGN

Price (delayed)

$1

Market cap

$339.11M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.26

Enterprise value

$326.73M

?
Relative Growth: Rel. Growth: 24
Relative Strength: Rel. Strength: 9
Relative Valuation: Rel. Valuation: 5
Relative Profitability: Rel. Profitability: 20

Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the ...

Highlights
OCGN's revenue is down by 3.7% YoY but it is up by 2.6% from the previous quarter
Ocugen's gross profit has decreased by 3.7% YoY but it has increased by 2.6% QoQ
The debt has soared by 168% YoY and by 164% from the previous quarter
OCGN's quick ratio has dropped by 52% since the previous quarter and by 51% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://ocugen.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of OCGN

OCGN stock price

How has the Ocugen stock price performed over time
Intraday
-3.85%
1 week
0.16%
1 month
-28.06%
1 year
-39.76%
YTD
-25.93%
QTD
-34.64%

Financial performance

How have Ocugen's revenue and profit performed over time
Revenue
$4.58M
Gross profit
$4.58M
Operating income
-$68.9M
Net income
-$81.81M
Gross margin
100%
Net margin
-1,786.3%
The net margin has contracted by 49% YoY and by 11% from the previous quarter
The net income fell by 44% YoY and by 14% QoQ
The company's operating margin fell by 29% YoY
The operating income has declined by 24% year-on-year and by 4% since the previous quarter

Price vs fundamentals

How does OCGN's price correlate with its fundamentals

Growth

What is Ocugen's growth rate over time

Valuation

What is Ocugen stock price valuation
P/E
N/A
P/B
N/A
P/S
73.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
71.34
The EPS has declined by 30% year-on-year and by 8% since the previous quarter
The price to sales (P/S) is 28% less than the last 4 quarters average of 107.5
OCGN's revenue is down by 3.7% YoY but it is up by 2.6% from the previous quarter

Efficiency

How efficient is Ocugen business performance
The ROIC has plunged by 103% YoY and by 89% from the previous quarter
The return on sales has declined by 42% year-on-year and by 8% since the previous quarter
The return on assets has declined by 34% year-on-year but it has grown by 14% since the previous quarter

Dividends

What is OCGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OCGN.

Financial health

How did Ocugen financials performed over time
OCGN's total assets is 12% smaller than its total liabilities
The company's total liabilities has surged by 179% YoY and by 175% QoQ
OCGN's total assets has surged by 132% year-on-year and by 118% since the previous quarter
The debt to equity has dropped by 193% since the previous quarter and by 149% year-on-year
The debt has soared by 168% YoY and by 164% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.